智通财经APP讯，兆科眼科-B(06622)发布公告，美国食品药品监督管理局(FDA)已批准公司就环孢素眼用凝胶(公司核心产品之一，前称环孢素A眼凝胶)用于治疗中重度干眼症作出的新药临床试验申请。该项即将进行的研究将为一项第三期、多中心、随机、双盲、活性对照研究。
基于与FDA进行的全面科学沟通及讨论，公司已与FDA达成一致意见，将已完成的关键第III期临床试验(COSMO研究)以及正在中国进行的第III期临床试验的数据纳入其美国开发计划。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.